Eiger BioPharmaceuticals stock holds a dated market value

Published on 09/22/2026 at 06:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eiger BioPharmaceuticals stock had a market value of USD 13,200 on September 22, 2026. Its 52-week range was also recorded.

EIGR, US28249U1051, Illustration mit AI erstellt.

Eiger BioPharmaceuticals (ISIN US28249U1051) carried a quoted market value of USD 13,200 on September 22, 2026, according to the available dated market snapshot. The same snapshot recorded a 52-week high of USD 13,200 and a 52-week low of USD 13,200.

Market figures set the frame

The three dated market figures point to a narrow reported range: the quoted value, the 52-week high, and the 52-week low were each USD 13,200 on September 22, 2026. This is a concrete comparison between the current reported value and the stated annual range, although the available data do not provide a separate verified Nasdaq closing price or percentage change.

Company identity and reporting context

Eiger BioPharmaceuticals is identified by ISIN US28249U1051. The available dated material does not provide a sufficiently substantiated reporting-period figure for revenue, earnings, cash flow, guidance, or another current operating metric, so the article uses the dated market values as its measurable reference points.

Dated value remains the reference

For Eiger BioPharmaceuticals stock, the reported USD 13,200 value on September 22, 2026 is the central observable market figure. The 52-week high and low at the same USD 13,200 level provide the accompanying historical range stated in the market snapshot.